Citations

Mayo Clinic

Showing 10 of 108602 citations.

A novel case of homozygous PAX1 mutation associated with hypoparathyroidism
Hamel, Benjamin , Kumar, Seema , Heidenreich, Leah, Joshi, Avni Y. , DaSilva, Christiana, Asumda, Faizal Z., Joshi, Avni, Heidenreich, Leah S.

Therapeutic Advances in Rare Disease | March 11, 2023 | Volume: 4 | Issue: No issue available | Pages: No page available

10.1177/26330040231158776 | PMID 37197558 Get It

The PAX1 gene plays an important role in the development of the parathyroid glands and the thymus. Mouse knockout models of PAX1, PAX3, and PAX9 have been found to have hypoplastic or absent parathyroid glands. To our knowledge, there are no reported cases of PAX1-associated hypoparathyroidism in humans. We present a case of hypoparathyroidism in a 23-month-old boy with a homozygous pathogenic variant in the PAX1 gene ( PAX1 NM_006192.5 c.463_465del variant), predicted to cause an in-frame deletion of asparagine at position 155 (p.Asn155del) of the PAX1 protein. The hypoparathyroidism was unmasked after the patient developed significant hypocalcemia while receiving GoLYTELY (polyethylene glycol 3350, sodium sulfate anhydrous, sodium bicarbonate, sodium chloride, potassium chloride) for bowel cleanout. The patient had mild and asymptomatic hypocalcemia prior to hospitalization. The patient was noted to have inappropriately normal parathyroid hormone (PTH) level at the time of documented hypocalcemia thereby suggesting a diagnosis of hypoparathyroidism. Plain language summary The first human case of hypoparathyroidism associated with a rare genetic disorder: a case report of PAX1 gene mutation The paired box ( PAX) gene family is important for embryo development. One subfamily, PAX1, is necessary for development of the spinal column, thymus (important for the immune system development), and parathyroid (helps regulate the amount of calcium in the body). We present the case of a 23-month-old boy with known PAX1 gene mutation who came in with episodes of vomiting and poor growth. His presentation was thought to be most likely related to constipation. He was started on bowel cleanout medication and intravenous fluids. However, his calcium that had been mildly low subsequently dropped to very low levels. The level of parathyroid hormone (which helps regulate calcium levels) was inappropriately normal, meaning that his body was unable to make more, and was consistent with hypoparathyroidism. He was treated with calcium supplements and vitamin D and calcium levels normalized. He continues to be on calcium and vitamin D and calcium levels have remained stable. Doctors should keep this complication in mind when treating patients with PAX1 gene mutation.
Clinical And Echocardiographic Predictors Of Recovery Of Moderate-To-Severe Sepsis-Associated Acute Kidney Injury In Critically Ill Patients
MUKHTAR, Osama, Lal, Amos , Jentzer, Jacob, Lal, Amos , Mukhtar, Osama , Tabi, Meir , Jentzer, Jacob C. , Kashani, Kianoush

Journal of Community Hospital Internal Medicine Perspectives | March 11, 2023 | Volume: 13 | Issue: 2 | Pages: No page available

10.55729/2000-9666.1159 | PMID 37168057 Get It

Background: Acute kidney injury (AKI) is associated with significant short- and long-term morbidity and mortality. In critically ill patients with sepsis, AKI tends to be more severe, more likely to require kidney replacement therapy (KRT), with less chance of recovery. Consequently, critically ill patients with sepsis-associated AKI (SA-AKI) have extended intensive care unit (ICU) stays and higher mortality rates. This study evaluated the predictive value of clinical and transthoracic echocardiographic (TTE) parameters for recovery from moderate-to-severe SA-AKI in critically ill patients. Methods: This single-center historical cohort study was conducted at a tertiary academic medical center. We analyzed the data of all adults (age ≥ 18 years) admitted to the ICU at Mayo Clinic, Rochester, MN, from June 1, 2018, to December 31, 2020. We included all patients who developed sepsis within the initial 24 h of their ICU stay. Results: We identified 2,919 eligible septic patients with available TTE, among which 1,431 patients (49%) had moderate-to-severe SA-AKI. The mean age of the patients was 68 ± 15 years, and the male-to-female ratio was 1.3:1. The most common comorbidities were diabetes mellitus and chronic lung and kidney diseases. Clinical predictors associated with SA-AKI non-recovery were the presence of stage III AKI (HR 1.5, 95% CI 1.0-2.1, p = 0.03) and utilization of kidney replacement therapy (KRT) (HR 6.8, 95% CI 3.6-12.4, p = 0.01). On the other hand, higher TAPSE was the only TTE variable associated with SA-AKI recovery (HR 1.1; 95% CI 1.08-1.15; p = 0.01). Conclusion: Our data from a single-center provide new information on the clinical (AKI stage, utilization of KRT, BMI, and peak serum creatinine) and echocardiographic features (TAPSE) associated with improved recovery in SA-AKI. There is a definite knowledge gap in the current literature regarding optimizing recovery in moderate-to-severe SA-AKI. Larger, multi-center studies are required to confirm these findings.
Case report of Acute Q fever with Hepatitis progressing to Chronic Q fever with Endocarditis
Jama, Abbas B., Sheehy, Jessica L., Attallah, Noura , Hassan, Esraa , Mushtaq, Hisham, Mousa, Omar Y. , Milavetz, James J., Sadik, Ali, Labban, Mohamad El , Jain, Nitesh , Urena, Eric O. Gomez, Khan, Syed Anjum , Mohamed, Hassan, Labban, Mohamad E, Gomez Urena, Eric O, Jama, Abbas B, Sheehy, Jessica, Mohamed, Hassan, Hassan, Esraa, Khedr, Anwar , Surani, Salim

Journal of Community Hospital Internal Medicine Perspectives | March 11, 2023 | Volume: 13 | Issue: 2 | Pages: No page available

10.55729/2000-9666.1155 | PMID 37168063 Get It

A 35-year-old male greenhouse worker presented with myalgia, fatigue, and fever. Initially, he was thought to have an unspecified viral infection and was treated with conservative therapy. However, the patient’s symptoms persisted, and he reported additional symptoms of mild abdominal pain and headaches. Laboratory evaluation was significant for elevated liver enzymes. Due to concern for acute hepatitis and persistent fever the patient was hospitalized. During his hospital course, no infectious etiology was found to explain his symptoms. After discharge from the hospital, additional testing showed positive serology for Q fever IgG phase II antibody (1:8192) and phase II antibody IgM (> 1:2048). He was treated with doxycycline and had a good clinical response. Upon follow-up, he had worsening Phase I IgG serologies. Transesophageal echo demonstrated vegetations consistent with endocarditis.
Patient‐reported experiences with migraine‐related cognitive symptoms: Results of the MiCOAS qualitative study
Gerstein, Maya T. , Uzumcu, Alyssa, McGinley, James S., Buse, Dawn C. , Cooke, Alexis , Touba, Nancy M., Nishida, Tracy K., Dodick, David W , Lipton, R.B. , Wirth, Robert J. , Houts, Carrie R. , McCarrier, Kelly P. , Goadsby, Peter J. , Dodick, David W. , Lipton, Richard B.

Headache: The Journal of Head and Face Pain | March 11, 2023 | Volume: 63 | Issue: 3 | Pages: 441-454

10.1111/head.14484 | PMID 36905166 Get It

Abstract Objectives To capture patients' perspectives on migraine‐related cognitive symptoms during pre‐headache, headache, post‐headache, and interictal periods. Background Migraine‐related cognitive symptoms are reported by people with migraine both during and between attacks. Associated with disability, they are increasingly viewed as a priority target for treatment. The Migraine Clinical Outcome Assessment System (MiCOAS) project is focused on developing a patient‐centered core set of outcome measures for the evaluation of migraine treatments. The project focuses on incorporating the experience of people living with migraine and the outcomes most meaningful to them. This includes an examination of the presence and functional impact of migraine‐related cognitive symptoms and their perceived impact on quality of life and disability. Methods Forty individuals with self‐reported medically diagnosed migraine were recruited via iterative purposeful sampling for semi‐structured qualitative interviews conducted using audio‐only web conferencing. Thematic content analysis was performed to identify key concepts around migraine‐related cognitive symptoms. Recruitment continued until concept saturation was achieved. Results Participants described symptoms consistent with migraine‐related deficits in language/speech, sustained attention, executive function, and memory that manifest during pre‐headache (36/40 [90%] reported ≥1 cognitive feature), headache (35/40 [88%] reported ≥1 cognitive feature), post‐headache (27/40 [68%] reported ≥1 cognitive feature), and interictal periods (13/40 [33%] reported ≥1 cognitive feature). Among participants reporting cognitive symptoms during pre‐headache, 32/40 (81%) endorsed 2–5 cognitive symptoms. Findings were similar during the headache phase. Participants reported language/speech problems consistent with, for example, impairments in receptive language, expressive language, and articulation. Issues with sustained attention included fogginess, confusion/disorientation, and trouble with concentration/focus. Deficits in executive function included difficulty processing information and reduced capacity for planning and decision‐making. Memory issues were reported across all phases of the migraine attack. Conclusions This patient‐level qualitative study suggests that cognitive symptoms are common for persons with migraine, particularly in the pre‐headache and headache phases. These findings highlight the importance of assessing and ameliorating these cognitive problems.
Presence of an Arterial Feeding Vessel on Cross-Sectional Imaging Predicts Treatment Response and Survival after Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Retrospective Multivariable Analysis of 138 Patients
Guan, Justin J. , McBride, Aaron , Huang, Lihong , Dunlay, Michael , Laroia, Sandeep , Sun, Shiliang , Yang, Jingzhen Ginger , Nagpal, Prashant

Digestive Disease Interventions | March 10, 2023 | Volume: 07 | Issue: 03 | Pages: 169-179

10.1055/s-0043-1760728 Get It

AbstractFinding a feeding vessel with diameter greater than 0.9 mm during transarterial chemoembolization (TACE) for hepatocellular cancer (HCC) has been shown to predict tumor necrosis on subsequent pathology. However, whether this translates into a useful clinical predictor for post-chemoembolization response and survival is unknown. This study aimed to determine whether the presence of an arterial feeder on pre-TACE cross-sectional imaging is associated with treatment response and survival after TACE for unresectable HCC. Retrospective medical record search for all chemo-embolizations performed for HCC from 2015 to 2016 yielded 138 patients who underwent 275 TACE sessions spanning 2011 to 2017. Patients consisted of 98 males (71%) with mean age of 62 (range, 37–86). Each patient underwent an average of two TACE sessions (range, 1–11). Endpoints included target tumor response and overall response defined by the mRECIST criteria, as well as patient survival. Preprocedural MRI/CT was reviewed for the presence of arterial feeder. Multivariable logistic regressions and Cox proportional hazard regressions were used to assess the effects of arterial feeder presence on treatment response and survival, respectively, adjusting for other covariates. Overall response was seen in 69% of patients. Arterial feeder was present on preprocedural cross-sectional imaging for 28% of TACE sessions. Median survival was 26.5 months (interquartile range, 13.2–38.1). The presence of arterial feeder led to better target tumor response (OR = 11.9, p < 0.0001), overall response (OR = 9.3, p < 0.0001), and improved survival (HR = 0.55, p = 0.02). The presence of an arterial feeder on pre-TACE cross-sectional imaging is associated with target tumor response, overall response, and survival after TACE.
AAPM task group report 275.S: Survey strategy and results on plan review and chart check practices in US and Canada
Harmsen, William S. , Johnson, Jennifer L. , Wells, Michelle, Santos, Luis E. Fong de los, Fong de Los Santos, Luis E, Schofield, Deborah , Conroy, Leigh , Dong, Lei

Journal of Applied Clinical Medical Physics | March 10, 2023 | Volume: 24 | Issue: 4 | Pages: No page available

10.1002/acm2.13952 | PMID 36897824 Get It

AbstractBackgroundAAPM Task Group (TG) 275 was charged with developing practical, evidence‐based recommendations for physics plan and chart review clinical processes for radiation therapy. As part of this charge, and to characterize practices and clinical processes, a survey of the medical physics community was developed and conducted. Detailed analyses and trends based on the survey that exceeded TG report length constraints are presented herein.AimsThe design, development, and detailed results of the TG‐ 275 survey as well as statistical analysis and trends are described in detail. This is complementary material to the TG 275 report.Methods and materialsThe survey consisted of 100 multiple‐choice questions divided into four main sections: 1) Demographics, 2) Initial Plan Check, 3) On‐Treatment, and 4) End‐of‐Treatment Chart Check. The survey was released to all AAPM members who self‐reported working in the radiation oncology field, and it was kept open for 7 weeks. Results were summarized using descriptive statistics. To study practice differences, tests of association were performed using data grouped by four demographic questions: 1) Institution Type, 2) Average number of patients treated daily, 3) Radiation Oncology Electronic Medical Record, and 4) Perceived Culture of Safety.ResultsThe survey captured 1370 non‐duplicate entries from the United States and Canada. Differences across practices were grouped and presented based on Process‐Based and Check‐Specific questions. A risk‐based summary was created to show differences amongst the four demographic questions for checks associated with the highest risk failure modes identified by TG‐275.ConclusionThe TG‐275 survey captured a baseline of practices on initial plan, on‐treatment, and end‐of‐treatment checks across a wide variety of clinics and institutions. The results of test of association showed practice heterogeneities as a function of demographic characteristics. Survey data were successfully used to inform TG‐275 recommendations.
Leveraging expertise and optimizing clinical research: Initial success of a pediatric epilepsy surgery collaborative
Koop, Jennifer I. , Ailion, Alyssa , Bearden, Donald J. , Boyer, Katrina, Cooper, Crystal , Decrow, Amanda M. , Duong, Priscilla, Espe‐Pfeifer, Patricia , Gabriel, Marsha, Hodges, Elise K. , Marshall, David , Molnar, Andrew E. , Olsen, Emily , Ono, Kim E , Patrick, Kristina E. , Paul, Brianna M., Romain, Jonathan, Sepeta, Leigh , Stilp, Rebecca L.H., Wilkening, Greta , Zaccariello, Michael J. , Perry, Μ. Scott , Workgroup, the PERC Surgery, Gaillard, William D. , Eschbach, Krista , McNamara, Nancy , Gedela, Satyanarayana , Javarayee, Pradeep , Armstrong, Dallas , Berl, Madison , Koop, Jennifer I , Ailion, Alyssa , Bearden, Donald J , Cooper, Crystal M , Decrow, Amanda M , Espe-Pfeifer, Patricia , Hodges, Elise , Marshall, David F , Molnar, Andrew E , Olsen, Emily K , Ono, Kim E , Patrick, Kristina E , Sepeta, Leigh N , Zaccariello, Michael, Perry, Michael Scott , Eschbach, Krista , Gaillard, William D , McNamara, Nancy A , Javarayee, Pradeep K , Armstrong, Dallas Michael , Berl, Madison M. , McNally, Kelly A. , Zelko, Frank A. J. , Workgroup, the PERC Surgery

Epilepsia | March 10, 2023 | Volume: 64 | Issue: 6 | Pages: 1554-1567

10.1111/epi.17579 | PMID 36897767 Get It

AbstractObjectiveImprove data‐driven research to inform clinical decision‐making with pediatric epilepsy surgery patients by expanding the Pediatric Epilepsy Research Consortium Epilepsy Surgery (PERC‐Surgery) Workgroup to include neuropsychological data. This article reports on the process and initial success of this effort and characterizes the cognitive functioning of the largest multi‐site pediatric epilepsy surgery cohort in the United States.MethodsPediatric neuropsychologists from 18 institutions completed surveys regarding neuropsychological practice and the impact of involvement in the collaborative. Neuropsychological data were entered through an online database. Descriptive analyses examined the survey responses and cognitive functioning of the cohort. Statistical analyses examined which patients were evaluated and if composite scores differed by domain, demographics, measures used, or epilepsy characteristics.ResultsPositive impact of participation was evident by attendance, survey responses, and the neuropsychological data entry of 534 presurgical epilepsy patients. This cohort, ages 6 months to 21 years, were majority White and non‐Hispanic, and more likely to have private insurance. Mean intelligence quotient (IQ) scores were below to low average, with weaknesses in working memory and processing speed. Full‐scale IQ (FSIQ) was lowest for patients with younger age at seizure onset, daily seizures, and magnetic resonance imaging (MRI) abnormalities.SignificanceWe established a collaborative network and fundamental infrastructure to address questions outlined by the Epilepsy Research Benchmarks. There is a wide range in the age and IQ of patients considered for pediatric epilepsy surgery, yet it appears that social determinants of health impact access to care. Consistent with other national cohorts, this US cohort has a downward shift in IQ associated with seizure severity.
Promoting diversity in neurosurgery through a virtual symposium
Charles, Antoinette J. , Seas, Andreas , Corley, Jacquelyn, Duvall, Julia B. , Owolo, Edwin , Abu-Bonsrah, Nancy , Elsamadicy, Aladine A. , Simpson, Venita M., Sanusi, Olabisi , Holly, Langston T. , Levi, Allan D. , Quiñones‐Hinojosa, Alfredo , Karikari, Isaac O. , Fuller, Anthony T. , Rodriguez, Analiz , Nduom, Edjah Kweku-Ebura , Liau, Linda M. , Grant, Gerald A. , Goodwin, C. Rory

Journal of Neurosurgery | March 10, 2023 | Volume: 139 | Issue: 4 | Pages: 1101-1108

10.3171/2023.1.jns221743 | PMID 36905659 Get It

OBJECTIVE The rates of women and underrepresented racial and ethnic minority (UREM) students successfully matching into neurosurgical residency are extremely low and do not reflect the makeup of the general population. As of 2019, only 17.5% of neurosurgical residents in the United States were women, 4.95% were Black or African American, and 7.2% were Hispanic or Latinx. Earlier recruitment of UREM students will help to diversify the neurosurgical workforce. Therefore, the authors developed a virtual educational event for undergraduate students entitled "Future Leaders in Neurosurgery Symposium for Underrepresented Students’’ (FLNSUS). The primary objectives of the FLNSUS were to expose attendees to 1) neurosurgeons from diverse gender, racial, and ethnic backgrounds; 2) neurosurgical research; 3) opportunities for neurosurgical mentorship; and 4) information about life as a neurosurgeon. The authors hypothesized that the FLNSUS would increase student self-confidence, provide exposure to the specialty, and reduce perceived barriers to a neurosurgical career. METHODS To measure the change in participant perceptions of neurosurgery, pre- and postsymposium surveys were administered to attendees. Of the 269 participants who completed the presymposium survey, 250 participated in the virtual event and 124 completed the postsymposium survey. Paired pre- and postsurvey responses were used for analysis, yielding a response rate of 46%. To assess the impact of participant perceptions of neurosurgery as a field, pre- and postsurvey responses to questions were compared. The change in response was analyzed, and a nonparametric sign test was performed to check for significant differences. RESULTS According to the sign test, applicants showed increased familiarity with the field (p < 0.001), increased confidence in their abilities to become neurosurgeons (p = 0.014), and increased exposure to neurosurgeons from diverse gender, racial, and ethnic backgrounds (p < 0.001 for all categories). CONCLUSIONS These results reflect a significant improvement in student perceptions of neurosurgery and suggest that symposiums like the FLNSUS may promote further diversification of the field. The authors anticipate that events promoting diversity in neurosurgery will lead to a more equitable workforce that will ultimately translate to enhanced research productivity, cultural humility, and patient-centered care in neurosurgery.
NCCN Guidelines® Insights: Prostate Cancer Early Detection, Version 1.2023
Moses, Kelvin A. , Sprenkle, Preston C. , Box, Geoffrey N., Carlsson, Sigrid , Catàlona, William J. , Dahl, Douglas M. , Dall’Era, Marc , Davis, John W. , Epstein, Jonathan I. , Etzioni, Ruth B., Farrington, Thomas A., Garraway, Isla P. , Jarrard, David F. , Kauffman, Eric, Kaye, Deborah R. , Kibel, Adam S. , LaGrange, Chad A. , Maroni, Paul, Ponsky, Lee , Salami, Simpa S. , Shaneyfelt, Terrence, Smaldone, Marc C. , Sonn, Geoffrey A. , Tyson, Mark D. , Vapiwala, Neha , Wake, Robert, Washington, Samuel L. , Yu, Alice , Yuh, Bertram, Berardi, Ryan A., Freedman-Cass, Deborah A., Salami, Simpa S , Bahler, Clinton D. , Drake, Bettina F. , Etzioni, Ruth B., Reys, Brian D. , Sánchez, Alejandro , Seibert, Tyler M.

Journal of the National Comprehensive Cancer Network | March 10, 2023 | Volume: 21 | Issue: 3 | Pages: 236-246

10.6004/jnccn.2023.0014 | PMID 36898362 Get It

The NCCN Guidelines for Prostate Cancer Early Detection provide recommendations for individuals with a prostate who opt to participate in an early detection program after receiving the appropriate counseling on the pros and cons. These NCCN Guidelines Insights provide a summary of recent updates to the NCCN Guidelines with regard to the testing protocol, use of multiparametric MRI, and management of negative biopsy results to optimize the detection of clinically significant prostate cancer and minimize the detection of indolent disease.
Smoking Cessation, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
Shields, Peter G. , Balis, David S. , Davis, James M. , Edmondson, Donna, Feliciano, Joy, Hudmon, Karen Suchanek , Jaklitsch, Michael T. , McCarthy, Danielle E. , Ong, Michael , Prochaska, Judith J. , Sandoval, Argelia, Sheffer, Christine E. , Spencer, Sharon, Tindle, Hilary A. , Tong, Elisa K. , Triplette, Matthew , Urbanic, James J., Videtic, Gregory M.M. , Whitlock, C. Will, McCullough, Beth, Darlow, Susan, Warner, David, Thomas, Timothy K , Sheffer, Christine E , Davis, James M , Bierut, Laura Jean , Arenberg, Douglas A. , Cinciripini, Paul M , Hitsman, Brian L. , Leone, Frank T. , Ling, Pamela May , Park, Elyse R , Studts, Jamie L. , Tanvetyanon, Tawee , Warner, David O.

Journal of the National Comprehensive Cancer Network | March 10, 2023 | Volume: 21 | Issue: 3 | Pages: 297-322

10.6004/jnccn.2023.0013 | PMID 36898367 Get It

Although the harmful effects of smoking after a cancer diagnosis have been clearly demonstrated, many patients continue to smoke cigarettes during treatment and beyond. The NCCN Guidelines for Smoking Cessation emphasize the importance of smoking cessation in all patients with cancer and seek to establish evidence-based recommendations tailored to the unique needs and concerns of patients with cancer. The recommendations contained herein describe interventions for cessation of all combustible tobacco products (eg, cigarettes, cigars, hookah), including smokeless tobacco products. However, recommendations are based on studies of cigarette smoking. The NCCN Smoking Cessation Panel recommends that treatment plans for all patients with cancer who smoke include the following 3 tenets that should be done concurrently: (1) evidence-based motivational strategies and behavior therapy (counseling), which can be brief; (2) evidence-based pharmacotherapy; and (3) close follow-up with retreatment as needed.